Figure 4.
The mediation analysis by intracranial atherosclerotic stenosis (ICAS) of the association between neutrophil count and clinical outcome [(A) for poor outcome at 90 days; (B) for mRS score at 90 days). a, regression coefficient of the association between neutrophil count and ICAS; b, regression coefficient of the association between ICAS and clinical outcome, using neutrophil count and ICAS as independent variables; c, regression coefficient of the association between neutrophil count and clinical outcome; c′, regression coefficient of the association between neutrophil count and clinical outcome, using neutrophil count and ICAS as independent variables. The percentage difference of the coefficients (1–c/c′) is shown.
